BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2025 7:53:56 AM | Browse: 5 | Download: 3
 |
Received |
|
2025-08-04 09:27 |
|
Peer-Review Started |
|
2025-08-04 09:27 |
|
First Decision by Editorial Office Director |
|
2025-08-25 07:07 |
|
Return for Revision |
|
2025-08-25 07:07 |
|
Revised |
|
2025-09-07 04:16 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-27 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-27 06:53 |
|
Articles in Press |
|
2025-10-27 06:53 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-30 10:38 |
|
Publish the Manuscript Online |
|
2025-11-27 07:53 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Early screening for liver cancer must be performed
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zi-Han Liu, Wen-Jun Wang and Shuang-Suo Dang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| China Hepatitis Prevention and Control Foundation |
GRG202501 |
|
| Corresponding Author |
Shuang-Suo Dang, PhD, Professor, Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157 Xiwu Road, Xi’an 710004, Shaanxi Province, China. dang212@126.com |
| Key Words |
Hepatocellular carcinoma; Early screening; Risk stratification; Serum biomarkers; Liquid biopsy; Artificial intelligence |
| Core Tip |
Hepatocellular carcinoma imposes a significant disease burden globally, particularly in China, where early screening faces challenges of low screening rates and insufficient sensitivity of traditional methods. This review focuses on the potential of innovative strategies, including optimized combinations of serum biomarkers, advanced imaging techniques, and liquid biopsy, to enhance early diagnosis rates. We emphasize the need for multidisciplinary collaboration and risk stratification management to improve screening efficacy. |
| Publish Date |
2025-11-27 07:53 |
| Citation |
Liu ZH, Wang WJ, Dang SS. Early screening for liver cancer must be performed. World J Hepatol 2025; 17(11): 112675 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i11/112675.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i11.112675 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
